Analytical validation of a highly sensitive point-of-care system for cardiac troponin I determination
Background Highly sensitive cardiac troponin assays (hs-cTn) are not available as point-of-care (POC) measurements. As rapid testing cannot be achieved at the expense of clinical performance, there is an urgent need to develop and rigorously validate POC hs-cTn. Konica Minolta (KM) has recently developed a surface plasmon-field enhanced fluorescence spectroscopy-based POC hs-cTn I system. Methods We validated the analytical characteristics of the KM POC system according to the international guidelines. Results Limit of blank (LoB) and limit of detection (LoD) were 0.35 and 0.62 ng/L, respectively, hs-cTn I concentrations corresponding to a total CV of 20%, 10% and 5% were 1.5, 3.9 and 11.0 ng/L, respectively. Method comparison studies showed that KM calibration was successfully traced to higher-order references. Limit of quantitation (LoQ), i.e. the hs-cTn I concentration having a total error of measurement of ≤34%, was 10.0 ng/L. The upper reference limit (URL) for 600 healthy blood donors was calculated at 12.2 ng/L (90% confidence interval [CI]: 9.2-39.2), while sex-partitioned URLs were 20.6 (males) and 10.7 ng/L (females), respectively (p < 0.0001). KM assay measured hs-cTn I concentrations >LoD in 65.7% of all reference individuals, in 76.7% of males and in 54.7% of females, respectively. Conclusions The KM system joins the characteristics of POC systems to the analytical performance of hs-cTn.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
---|---|
Enthalten in: |
Clinical chemistry and laboratory medicine - 58(2019), 1 vom: 18. Dez., Seite 138-145 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Braga, Federica [VerfasserIn] |
---|
Links: |
---|
Themen: |
High sensitivity troponin |
---|
Anmerkungen: |
Date Completed 04.09.2020 Date Revised 13.09.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1515/cclm-2019-0801 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM302286152 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM302286152 | ||
003 | DE-627 | ||
005 | 20231225110411.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1515/cclm-2019-0801 |2 doi | |
028 | 5 | 2 | |a pubmed24n1007.xml |
035 | |a (DE-627)NLM302286152 | ||
035 | |a (NLM)31622244 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Braga, Federica |e verfasserin |4 aut | |
245 | 1 | 0 | |a Analytical validation of a highly sensitive point-of-care system for cardiac troponin I determination |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.09.2020 | ||
500 | |a Date Revised 13.09.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background Highly sensitive cardiac troponin assays (hs-cTn) are not available as point-of-care (POC) measurements. As rapid testing cannot be achieved at the expense of clinical performance, there is an urgent need to develop and rigorously validate POC hs-cTn. Konica Minolta (KM) has recently developed a surface plasmon-field enhanced fluorescence spectroscopy-based POC hs-cTn I system. Methods We validated the analytical characteristics of the KM POC system according to the international guidelines. Results Limit of blank (LoB) and limit of detection (LoD) were 0.35 and 0.62 ng/L, respectively, hs-cTn I concentrations corresponding to a total CV of 20%, 10% and 5% were 1.5, 3.9 and 11.0 ng/L, respectively. Method comparison studies showed that KM calibration was successfully traced to higher-order references. Limit of quantitation (LoQ), i.e. the hs-cTn I concentration having a total error of measurement of ≤34%, was 10.0 ng/L. The upper reference limit (URL) for 600 healthy blood donors was calculated at 12.2 ng/L (90% confidence interval [CI]: 9.2-39.2), while sex-partitioned URLs were 20.6 (males) and 10.7 ng/L (females), respectively (p < 0.0001). KM assay measured hs-cTn I concentrations >LoD in 65.7% of all reference individuals, in 76.7% of males and in 54.7% of females, respectively. Conclusions The KM system joins the characteristics of POC systems to the analytical performance of hs-cTn | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Validation Study | |
650 | 4 | |a high sensitivity troponin | |
650 | 4 | |a method evaluation | |
650 | 4 | |a point of care testing | |
650 | 7 | |a Troponin I |2 NLM | |
700 | 1 | |a Aloisio, Elena |e verfasserin |4 aut | |
700 | 1 | |a Panzeri, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Nakagawa, Takahito |e verfasserin |4 aut | |
700 | 1 | |a Panteghini, Mauro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d 1998 |g 58(2019), 1 vom: 18. Dez., Seite 138-145 |w (DE-627)NLM095304118 |x 1437-4331 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2019 |g number:1 |g day:18 |g month:12 |g pages:138-145 |
856 | 4 | 0 | |u http://dx.doi.org/10.1515/cclm-2019-0801 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 58 |j 2019 |e 1 |b 18 |c 12 |h 138-145 |